Y-Intercept (HK)’s Amneal Pharmaceuticals AMRX Stock Holding History

Y-Intercept (HK)’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.63M	Buy	130,358 +42,215	+48%	+$760K	0.06%	488
2026 Q2	$1.53M	Buy	88,143 +77,227	+707%	+$1.06M	0.03%	850
2026 Q1	$136K	Buy	+10,916	New	+$147K	﹤0.01%	1453
2025 Q1	–	Sell	-58,111	Closed	-$460K	–	1168
2024 Q4	$460K	Buy	58,111 +20,686	+55%	+$174K	0.03%	766
2024 Q3	$311K	Buy	+37,425	New	+$293K	0.02%	1002
2024 Q2	–	Sell	-28,123	Closed	-$170K	–	1361
2024 Q1	$170K	Buy	+28,123	New	+$159K	0.01%	1191
2023 Q4	–	Sell	-105,098	Closed	-$444K	–	1206
2023 Q3	$444K	Buy	105,098 +92,948	+765%	+$347K	0.04%	609
2023 Q2	$37.7K	Buy	+12,150	New	+$25.9K	﹤0.01%	1209

Other funds holding AMRX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Signature Wealth Management Partners Montvale, New Jersey $234M AUM 23.06% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Campbell Newman Asset Management Milwaukee, Wisconsin $1.33B AUM 26.63% 1-Year Est. Return

Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Y-Intercept (HK)'s AMRX Position: Q3 2026 in Review

Y-Intercept (HK) increased its Amneal Pharmaceuticals (AMRX) stake by 48% in Q3 2026, buying an estimated $760K and bringing the position to 130,358 shares worth $2.63M. The position accounts for 0.06% of the portfolio, ranked #488.

Y-Intercept (HK) first reported a position in AMRX in Q2 2023 and has held it in 8 quarters since. 65 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

Y-Intercept (HK) held 130,358 shares of Amneal Pharmaceuticals worth $2.63M as of Q3 2026.
Y-Intercept (HK) bought 42,215 Amneal Pharmaceuticals shares in Q3 2026, an estimated $760K.
Amneal Pharmaceuticals made up 0.06% of Y-Intercept (HK)'s portfolio in Q3 2026, its #488 holding.
Y-Intercept (HK) first reported a position in Amneal Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
65 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.